Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$78.22 USD
+0.54 (0.70%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $78.24 +0.02 (0.03%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/24/2024
Time: -- |
6/2024 | $1.10 | 0.00% |
Earnings Summary
For their last quarter, Dr. Reddys Laboratories (RDY) reported earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.86 per share. This reflects a positive earnings surprise of 9.30%. Look out for RDY's next earnings release expected on July 24, 2024. For the next earning release, we expect the company to report earnings of $1.10 per share, reflecting a year-over-year increase of 6.8%.
Earnings History
Price & Consensus
Zacks News for RDY
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
RDY: What are Zacks experts saying now?
Zacks Private Portfolio Services